Mevalonate deprivation impairs IGF-I/insulin: Signaling in human vascular smooth muscle cells

Atherosclerosis

Volumn 135, Issue 2, 1997, Pages 213-223

  Martínez González, José ^a   Viñals, Marisa ^a   Vidal, Francisco ^a   Llorente Cortés, Vicenta ^a   Badimon, Lina ^a  

^a CSIC   (Spain)

Author keywords

3 Hydroxy 3 methylglutaryl Coenzyme A reductase inhibitors; c fos; Insulin; Insulin like growth factor; Signaling pathways; Smooth muscle cell

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONIC ACID; SOMATOMEDIN C; STATIN;

AMINO ACID METABOLISM; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; DNA SYNTHESIS INHIBITION; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR DOWN REGULATION; REVASCULARIZATION; SMOOTH MUSCLE FIBER; STIMULUS RESPONSE; VASCULAR SMOOTH MUSCLE;

CELLS, CULTURED; DNA; GENE EXPRESSION REGULATION; GENES, FOS; GENES, RAS; GROWTH SUBSTANCES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LOVASTATIN; MEVALONIC ACID; MUSCLE, SMOOTH, VASCULAR; PROTEIN PROCESSING, POST-TRANSLATIONAL; PULMONARY ARTERY; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0344625376     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00164-0     Document Type: Article

References (45)

1. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
2. Roth M., Emmos L.R., Perruchoud A., Block L.H. Expression of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isomers. Proc Natl Acad Sci USA. 88:1991;1888-1892.
3. Soma M.R., Pagliarini P., Butti G., Paoletti R., Paoletti P., Fumagalli R. Simvastatin, an inhibitor of cholesterol biosynthesis, shows synergistic effect with N,N′-bis(2-chloroethyl)-N-nitrosourea and beta interferon on human glioma cells. Cancer Res. 52:1992;4348-4355.
4. O'Donnell M.P., Kasiske B.L., Atluru D., Keane W. Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest. 91:1993;83-87.
5. Corsini A., Mazzoti M., Raiteri M., Soma M.R., Gabbiani G., Fumagalli R., Paoletti R. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis. 101:1993;117-125.
6. Martínez-González J., Badimon L. Human and porcine smooth muscle cells share similar proliferation dependence on the mevalonate pathway. Implications for in vivo interventions in the porcine model. Eur J Clin Invest. 26:1996;1023-1032.
7. Finegold A.A., Shafer W.R., Rine J., Whiteway M., Tamanoi F. Common modifications of trimeric G proteins and ras protein: involvement of polyisoprenylation. Science. 249:1990;165-169.
8. Hall J.M., Haworth S.G. Onset and evolution of pulmonary vascular disease in young children: abnormal postnatal remodeling studied in lung biopsies. J Pathol. 166:1992;183-193.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
10. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis: a multifactorial disease. Circulation 1993;87:II3-II6.
11. Riabowol E.R., Vosatka J., Ziff E.B., Feramisco Jr. Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Moll Cell Biol. 8:1988;1670-1676.
12. Ledwith B.J., Manan S., Kraynat A.R., Nichols W.W., Bradley M.O. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene. Mol Cell Biol. 10:1990;1545-1555.
13. Sharma R.V., Bhalla R. PDGF-induced mitogenic signaling is not mediated through protein kinase C and c-fos pathway in VSM cells. Am J Physiol. 264:1993;C71-C79.
14. Indolfi C., Esposito G., Di-Lorenzo E., Rapacciuolo A., Feliciello A., Porcellini A., Avvedimento V.E., Condorelli M., Chiariello M. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 92:1995;1230-1235.
15. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 50:1971;172-186.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1989.
17. Curran T., Gordon M.B., Rubino K.L., Sambucetti L.C. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene. 2:1987;79-84.
18. Gerlach W.L., Bedbrook J.R. Cloning and characterization of ribosomal RNA genes from wheat and barley. Nucleic Acids Res. 7:1979;1869-1885.
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
20. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klent D.C. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
21. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
22. Traganos F., Darzynkiewicz Z., Melamed M.R. The ratio of RNA to total nucleic acid content as a quantitative measure of balanced cell growth. Cytometry. 21:1982;212-218.
23. Molloy C.J., Pawlowski J.E., Taylor D.S., Turner C.E., Weber H., Peluso M., Seiler S.M. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the Raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells. J Clin Invest. 97:1996;1173-1183.
24. Rothman A., Wolner B., Button D., Taylor P. Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells. J Biol Chem. 269:1994;6399-6404.
25. Porreca E., Ciccarelli R., Di Febbo C., Cuccurullo F. Protein kinase C pathway responses of aged and young rat vascular smooth muscle cells. Atherosclerosis. 104:1993;137-145.
26. 1/S inhibition. Exp Cell Res. 208:1993;311-320.
27. ras. J Biol Chem. 265:1990;5157-5160.
28. Casey P.J., Mooman J.F., Zhang F.L., Higgins J.B., Thissen J.A. Prenylation and G protein signaling. Recent Prog Horm Res. 49:1994;215-239.
29. Stacey D.W., Watson T., Kung H.-F., Curran T. Microinjection of transforming ras protein induces c-fos expression. Mol Cell Biol. 7:1987;523-527.
30. Van Der Geer P., Hunter T., Lindberg R.A. Receptor protein-tyrosine kinase and their signal transduction pathways. Ann Rev Cell Biol. 10:1994;251-337.
31. McNamara C.A., Sarembock I., Gimple L., Fenton J., Coughlin S.R., Owens G.K. Thrombin stimulates proliferation of cultured rat aortic SMC by a proteolytically activated receptor. J Clin Invest. 91:1993;94-98.
32. Chen Y.-H., Grall D., Salcini A.E., Pelicci P.G., Pouysségur J., Obberghen-Schilling E.V. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor. EMBO J. 15:1996;1037-1044.
33. Agarwal S., Corbley M.J., Roberts T. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system. Activation of c-jun and c-fos via multiple pathways. Oncogene. 11:1995;427-438.
34. Myers M.G., Sun X.J., White M.F. The IRS-1 signaling system. Trends Biochem Sci. 19:1994;289-293.
35. Skolnik E.Y., Lee C.-H., Batzer A., Vicentini L.M., Zhou M., Daly R., Myers M.J. Jr., Backer J.M., Ullrich A., White M.F., Schelessinger J. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS-1 and Shc: implication for insulin control of ras signaling. EMBO J. 12:1993;1929-1936.
36. Yamauchi K., Pessin J.E. Insulin receptor substrate-1 (IRS-1) and Shc compete for a limited pool of Grb2 in mediating insulin downstream signaling. J Biol Chem. 269:1994;31107-31114.
37. McGuire T.F., Xu X.Q., Corey S.J., Romero G.G., Sebti S.M. Lovastatin disrupts early events in insulin signaling: a potential mechanism of lovastatin's anti-mitogenic activity. Biochem Biophys Res Commun. 204:1994;399-406.
38. Xu X.-Q., McGuire T.F., Blaskovich M.A., Cebti S.M., Romero G. Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts. Arch Biochem Biophys. 326:1996;233-237.
39. Messina J.L. Insulin's regulation of c-fos gene transcription in hepatoma cells. J Biol Chem. 265:1990;11700-11705.
40. Delafontaine P., Lou H. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J Biol Chem. 268:1993;16866-16870.
41. Arnqvist H.J., Bornfeldt K.E., Chen Y., Lindström T. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism. 44:1995;58-66.
42. Delafontaine P., Anwar A., Lou H., Ku L. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest. 97:1996;139-145.
43. Hayry P., Myllarniemi M., Aavik E., Alatalo S., Aho P., Yilmaz S., Raisanen-Sokolowski A., Cozzone G., Jameson B.A., Baserga R. Stable D-peptide analog of insulin-like growth factor I inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J. 9:1995;1336-1344.
44. Du J., Delafontaine P. Inhibition of vascular smooth muscle cell growth through antisense transcription of rat insulin-like growth factor I receptor cDNA. Circ Res. 76:1995;963-972.
45. Sobel B.E. Potentiation of vasculopathy by insulin. Implications from an NHLBI clinical alert. Circulation. 93:1996;1613-1615.